Global Hadoop Market Report 2017: Analysis & Trends 2014-2016 & Industry Forecasts 2017-2025
Oct 06, 2017 11:15 am UTC| Business
Dublin, Oct. 06, 2017 -- The "Global Hadoop Market Analysis Trends - Industry Forecast to 2025" report has been added to Research and Markets' offering. The Global Hadoop Market is poised to grow...
Oct 06, 2017 11:03 am UTC| Business
CAMBRIDGE, Mass., Oct. 06, 2017 -- Voyager Therapeutics, Inc. (NASDAQ:VYGR), a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases announced today multiple...
The Ezold Law Firm, P.C. to be sponsor of KEIRETSU FORUM MID-ATLANTIC 5th ANGEL CAPITAL EXPO
Oct 06, 2017 11:03 am UTC| Business
PHILADELPHIA, PA , Oct. 06, 2017 -- For Immediate Release The Ezold Law Firm, P.C., a Sponsor of the Keiretsu Forum Mid-Atlantic, will also sponsor the 2017 Keiretsu Forum 5th Annual Angel Capital Expo at the Union...
Global $23.8 Bn Wearable Medical Devices Market, 2025
Oct 06, 2017 11:01 am UTC| Business
Dublin, Oct. 06, 2017 -- The "Global Wearable Medical Devices Market Analysis Trends - Industry Forecast to 2025" report has been added to Research and Markets' offering. The Global Wearable...
uniQure Announces FDA Orphan Drug Designation for AMT-130 in Huntington’s disease
Oct 06, 2017 11:00 am UTC| Business
LEXINGTON, Mass. and AMSTERDAM, The Netherlands, Oct. 06, 2017 -- uniQure N.V. (NASDAQ:QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced...
Extendicare Announces Timing of 2017 Third Quarter Results and Conference Call
Oct 06, 2017 11:00 am UTC| Business
MARKHAM, Ontario, Oct. 06, 2017 -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX:EXE) announced today that it plans to release its financial results for the third quarter of 2017 after market close on Thursday,...
Edge Therapeutics to Present at the Neurocritical Care Society 15th Annual Meeting
Oct 06, 2017 11:00 am UTC| Business
BERKELEY HEIGHTS, N.J., Oct. 06, 2017 -- Edge Therapeutics, Inc. (Nasdaq:EDGE), a clinical-stage biotechnology company developing novel hospital-based therapies for the management of acute, life-threatening conditions,...